Capricor Therapeutics (CAPR) Reports Q4 Loss of $0.21/Share

Capricor Therapeutics (NASDAQ: CAPR) reported Q4 EPS of ($0.21), versus ($0.21) reported last year.

For earnings history and earnings-related data on Capricor Therapeutics (CAPR) click here.

You May Also Be Interested In

• Greenbrier Cos. (GBX) Reports In-Line Q3 EPS
• Capricor Therapeutics (CAPR) 4500 contracts of August 30 calls and 2900 contracts of August 20 puts trade
• Trump's $1.2 billion D.C. spending spree fans fiscal fears as yields surge